摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[1,3-苯并二氧戊环-5-基-(羧基甲硫基)甲基]硫基乙酸 | 34914-27-7

中文名称
2-[1,3-苯并二氧戊环-5-基-(羧基甲硫基)甲基]硫基乙酸
中文别名
——
英文名称
benzo[1,3]dioxol-5-ylmethanediylbissulfanyl-bis-acetic acid
英文别名
benzo[1,3]dioxol-5-yl-bis-carboxymethylsulfanyl-methane;Benzo[1,3]dioxol-5-yl-bis-carboxymethylmercapto-methan;α,α'-(piperonylidenedithio)diacetic acid;Acetic acid, 2,2'-(piperonylidenedithio)DI-;2-[1,3-benzodioxol-5-yl(carboxymethylsulfanyl)methyl]sulfanylacetic acid
2-[1,3-苯并二氧戊环-5-基-(羧基甲硫基)甲基]硫基乙酸化学式
CAS
34914-27-7
化学式
C12H12O6S2
mdl
——
分子量
316.356
InChiKey
VNAYOZFFVJKRMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    20
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    144
  • 氢给体数:
    2
  • 氢受体数:
    8

SDS

SDS:80611ea540379ac46b5b3b330489d323
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Novel antibacterial agents
    申请人:Christensen G. Burton
    公开号:US20070134729A1
    公开(公告)日:2007-06-14
    This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands has a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.
    本发明涉及一种新型多结合化合物(药剂),其为抗菌剂。该发明的多结合化合物由2-10个配体通过连接剂或连接剂共价连接而成,其中每个单价(即未连接的)配体具有与细胞壁生物合成和代谢中的酶、合成细菌细胞壁和/或细菌细胞表面的前体有结合能力,从而干扰细胞壁的合成和/或代谢。特别地,本发明的多结合化合物由2-10个配体通过连接剂或连接剂共价连接而成,其中每个配体具有能够结合青霉素结合蛋白、横向肽酶酶、横向肽酶酶底物、β-内酰胺酶、青霉素酶、头孢菌素酶、横向转移酶酶或横向转移酶酶底物的配体结构域。优选地,配体选自β-内酰胺类或糖肽类抗菌剂。
  • Beta2-Adrenergic Receptor Agonists
    申请人:Moran Edmund J.
    公开号:US20080269344A1
    公开(公告)日:2008-10-30
    Disclosed are multibinding compounds which are β2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.
    本发明涉及多结合化合物,其是β2肾上腺素能受体激动剂,可用于治疗和预防哮喘、支气管炎等呼吸系统疾病。它们还可用于治疗神经系统损伤和早产。
  • Beta2-adrenergic receptor agonists
    申请人:Moran J. Edmund
    公开号:US20070179179A1
    公开(公告)日:2007-08-02
    Disclosed are multibinding compounds which are β2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.
    本发明涉及多重结合化合物,其为β2肾上腺素能受体激动剂,可用于治疗和预防哮喘、支气管炎等呼吸系统疾病。它们还可用于治疗神经系统损伤和早产。
  • Muscarinic receptor antagonists
    申请人:Aggen James
    公开号:US20090306134A1
    公开(公告)日:2009-12-10
    Disclosed are multibinding compounds which are muscarinic receptor antagonists. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is, independently of each other, a muscarinic receptor antagonist or an allosteric modulator provided that at least one of said ligand is a muscarinic receptor antagonist. The multibinding compounds of this invention are useful in the treatment and prevention of diseases such as chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, urinary incontinence, and the like.
    本发明涉及一种多结合化合物,其为肌动蛋白受体拮抗剂。该发明的多结合化合物包含2至10个配体共价连接到一个或多个连接体上。每个配体是独立的,可以是肌动蛋白受体拮抗剂或变构调节剂,但至少其中一个配体是肌动蛋白受体拮抗剂。本发明的多结合化合物在治疗和预防慢性阻塞性肺疾病、慢性支气管炎、肠易激综合征、尿失禁等疾病方面具有用途。
  • Use of compounds containing a thio-ether, sulphoxide or sulphone function as cosmetic anti-pollution agent
    申请人:——
    公开号:US20040037856A1
    公开(公告)日:2004-02-26
    The invention concerns the use for topical application of compounds containing a thio-ether, sulphoxide or sulphone function as cosmetic anti-pollution agent and a cosmetic treatment method to obtain protection of the organism against pollution effects.
    本发明涉及将含有硫醚、亚砜或砜官能团的化合物用作化妆品抗污染剂的局部应用,以及保护生物体免受污染影响的化妆品处理方法。
查看更多

同类化合物

(5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) 黄樟素氧化物 黄樟素乙二醇; 2',3'-二氢-2',3'-二羟基黄樟素 黄樟素 风藤酰胺 非哌西特盐酸盐 非哌西特 盐酸盐 角秋水仙碱 螺[1,3-苯并二氧戊环-2,1'-环己烷]-5-胺 蓝细菌 苯并[d][1,3]二氧杂环戊烯-5-胺盐酸盐 苯并[d][1,3]二氧代l-5-甲基(2-氧代乙基)氨基甲酸叔丁酯 苯并[d][1,3]二氧代l-5-氨基甲酸叔丁酯 苯并[d][1,3]二氧代-4-甲腈 苯并[d][1,3]二氧代-4-氨基甲酸叔丁酯 苯并[d[1,3]二氧代-4-羧酰胺 苯并[1,3]二氧杂环戊烯-5-基甲基2-氯乙酸酯 苯并[1,3]二氧杂环戊烯-5-基甲基-苄基-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-[2-(4-氟-苯基)-乙基]-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(四氢-呋喃-2-基甲基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(2-氟-苄基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(1-甲基-哌啶-4-基)-胺 苯并[1,3]二氧代l-5-甲基-吡啶-3-甲基-胺 苯并[1,3]二氧代l-5-甲基-(4-氟-苄基)-胺 苯并[1,3]二氧代l-5-乙酸甲酯 苯并[1,3]二氧代-5-羧酰胺盐酸盐 苯并[1,3]二氧代-5-甲基肼盐酸盐 苯并[1,3]二氧代-5-甲基吡啶-4-甲胺 苯并[1,3]二氧代-5-甲基-吡啶-2-甲胺 苯并[1,3]二氧代-5-乙酰氯 苯并-1,3-二氧杂环戊烯-5-甲醇丙酸酯 苯乙酸,1-(1,3-苯并二氧杂环戊烯-5-基)-3-丁烯-1-基酯 苯乙酮O-((4-(3,4-亚甲二氧基苄基)-1-哌嗪-1-基)羰基甲基)肟 苯,1-甲氧基-6-硝基-3,4-亚甲二氧基- 芝麻酚 胡椒醛肟 胡椒醛,二苄基缩硫醛 胡椒醛 胡椒醇 胡椒酸酰氯 胡椒酸 胡椒腈 胡椒环乙酮肟 胡椒环 胡椒基重氮酮 胡椒基甲醛 胡椒基氯 胡椒基戊二烯酸钾 胡椒基丙醛 胡椒基丙酮